Evidence map›Paper›PMID 38762586›Full record

ArticleScientific reports2024

Prevalence and determinants of moderate-to-severe anaemia in the third trimester of pregnancy: a multicenter cross-sectional study in Lagos, Nigeria.

Kehinde S Okunade, Festus O Olowoselu, Olufemi A Oyedeji, Yusuf A Oshodi, Aloy O Ugwu, Ayokunle M Olumodeji, Adebola A Adejimi, Muisi A Adenekan, Temitope Ojo, Iyabo Y Ademuyiwa and 7 more

Abstract readMulticenter Study
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Kehinde S OkunadeDepartment of Obstetrics & Gynaecology, College of Medicine, University of Lagos/Lagos University Teaching Hospital, PMB 12003, Lagos, Nigeria. sokunade@unilag.edu.ng.
Festus O OlowoseluDepartment of Haematology and Blood Transfusion, College of Medicine, University of Lagos, Lagos, Nigeria.
Olufemi A OyedejiDepartment of Haematology and Blood Transfusion, College of Medicine, University of Lagos, Lagos, Nigeria.
Yusuf A OshodiDepartment of Obstetrics & Gynaecology, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria.
Aloy O UgwuDepartment of Obstetrics & Gynaecology, 68 Nigerian Army Reference Hospital, Yaba, Lagos, Nigeria.
Ayokunle M OlumodejiDepartment of Obstetrics & Gynaecology, Lagos State University Teaching Hospital, Ikeja, Lagos, Nigeria.
Adebola A AdejimiDepartment of Community Health & Primary Care, College of Medicine, University of Lagos, Surulere, Lagos, Nigeria.
Muisi A AdenekanDepartment of Obstetrics & Gynaecology, Lagos Island Maternity Hospital, Lagos Island, Lagos, Nigeria.
Temitope OjoDepartment of Obstetrics & Gynaecology, Federal Medical Center, Ebute-Meta, Lagos, Nigeria.
Iyabo Y AdemuyiwaDepartment of Nursing Science, College of Medicine, University of Lagos, Surulere, Lagos, Nigeria.
Victoria AdaramoyeDepartment of Obstetrics & Gynaecology, Lagos University Teaching Hospital, Lagos, Nigeria.
Austin C OkoroDepartment of Obstetrics & Gynaecology, Lagos University Teaching Hospital, Lagos, Nigeria.
Atinuke OloweDepartment of Nursing Science, College of Medicine, University of Lagos, Surulere, Lagos, Nigeria.
Hameed AdelabuCenter for Clinical Trials, Research and Implementation Science, College of Medicine, University of Lagos, Surulere, Lagos, Nigeria.
Olukayode O AkinmolaDepartment of Chemical Pathology, Lagos University Teaching Hospital, Surulere, Lagos, Nigeria.
Salimat Yusuf-AwesuDepartment of Obstetrics & Gynaecology, Lagos University Teaching Hospital, Lagos, Nigeria.
Ayodeji A OluwoleDepartment of Obstetrics & Gynaecology, College of Medicine, University of Lagos/Lagos University Teaching Hospital, PMB 12003, Lagos, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The high burden of anaemia during pregnancy underscores the urgent need to gain a comprehensive understanding of the factors contributing to its widespread occurrence. Our study assessed the prevalence and the trends of moderate-to-severe anaemia (MSA) in late pregnancy (28 to 36 weeks) and then investigated the key determinants driving this prevalence among women in Lagos, Nigeria. We conducted a secondary data analysis involving 1216 women enrolled in the Predict-PPH study between January and March 2023. We employed a multivariate binary logistic regression model with a backward stepwise selection approach to identify significant predictors of MSA. The study revealed a 14.5% prevalence of MSA during pregnancy. Independent predictors of MSA included having given birth to two or more children (adjusted odds ratio = 1.46, 95% confidence interval: 1.03-2.07), having a maternal body mass index (BMI) of 28 kg/m

Indexed as

AnemiaPregnancy Complications, HematologicPregnancy Trimester, ThirdAdultBody Mass IndexCross-Sectional StudiesFemaleHumansNigeriaPregnancyPrevalenceRisk FactorsYoung AdultBMILagosModerate-to-severe anaemiaPredictorsPredict-PPH

Identifiers

PMID38762586
PMCPMC11102504

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.